【Description】
Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.
Next Generation Antibody Therapeutics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Next Generation Antibody Therapeutics market is projected to reach US$ 39450 million in 2029, increasing from US$ 9601 million in 2022, with the CAGR of 21.5% during the period of 2023 to 2029. Demand from Cancer and Haemophilia are the major drivers for the industry.
Global key players of next generation antibody therapeutics include Roche, Seagen, Amgen, Pfizer, Takeda, etc. The top two players hold a share over 70%. North America is the largest market, has a share about 65%, followed by Europe and Asia-Pacific, with share 16% and 15%, separately. In terms of product type, Antibody Drug Conjugate (ADC) is the largest segment, occupied for a share of 60%, and in terms of application, Cancer has a share about 66 percent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Next Generation Antibody Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report:
By Company
Roche
Amgen
Pfizer
Takeda
Daiichi Sankyo
Seagen
Astellas
Immunomedics
GSK
Immunocore
ADC Therapeutics
Segment by Type
Antibody Drug Conjugate (ADC)
Bispecific Antibody (BsAb)
Segment by Application
Cancer
Haemophilia
Other Non-Cancer Diseases
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Next Generation Antibody Therapeutics market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Next Generation Antibody Therapeutics introduction, etc. Next Generation Antibody Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Next Generation Antibody Therapeutics market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.
【Table of Contents】
1 Market Overview of Next Generation Antibody Therapeutics
1.1 Next Generation Antibody Therapeutics Market Overview
1.1.1 Next Generation Antibody Therapeutics Product Scope
1.1.2 Next Generation Antibody Therapeutics Market Status and Outlook
1.2 Global Next Generation Antibody Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Next Generation Antibody Therapeutics Market Size by Region (2018-2029)
1.4 Global Next Generation Antibody Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Next Generation Antibody Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Next Generation Antibody Therapeutics Market Size (2018-2029)
1.6.1 North America Next Generation Antibody Therapeutics Market Size (2018-2029)
1.6.2 Europe Next Generation Antibody Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Next Generation Antibody Therapeutics Market Size (2018-2029)
1.6.4 Latin America Next Generation Antibody Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Next Generation Antibody Therapeutics Market Size (2018-2029)
2 Next Generation Antibody Therapeutics Market by Type
2.1 Introduction
2.1.1 Antibody Drug Conjugate (ADC)
2.1.2 Bispecific Antibody (BsAb)
2.2 Global Next Generation Antibody Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Next Generation Antibody Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Next Generation Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Next Generation Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Next Generation Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Next Generation Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Next Generation Antibody Therapeutics Revenue Breakdown by Type (2018-2029)
3 Next Generation Antibody Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Haemophilia
3.1.3 Other Non-Cancer Diseases
3.2 Global Next Generation Antibody Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Next Generation Antibody Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Next Generation Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Next Generation Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Next Generation Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Next Generation Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Next Generation Antibody Therapeutics Revenue Breakdown by Application (2018-2029)
4 Next Generation Antibody Therapeutics Competition Analysis by Players
4.1 Global Next Generation Antibody Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2022)
4.3 Date of Key Players Enter into Next Generation Antibody Therapeutics Market
4.4 Global Top Players Next Generation Antibody Therapeutics Headquarters and Area Served
4.5 Key Players Next Generation Antibody Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Next Generation Antibody Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Next Generation Antibody Therapeutics Products, Services and Solutions
5.1.4 Roche Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Next Generation Antibody Therapeutics Products, Services and Solutions
5.2.4 Amgen Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Amgen Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Next Generation Antibody Therapeutics Products, Services and Solutions
5.3.4 Pfizer Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Next Generation Antibody Therapeutics Products, Services and Solutions
5.4.4 Takeda Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Takeda Recent Developments
5.5 Daiichi Sankyo
5.5.1 Daiichi Sankyo Profile
5.5.2 Daiichi Sankyo Main Business
5.5.3 Daiichi Sankyo Next Generation Antibody Therapeutics Products, Services and Solutions
5.5.4 Daiichi Sankyo Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Daiichi Sankyo Recent Developments
5.6 Seagen
5.6.1 Seagen Profile
5.6.2 Seagen Main Business
5.6.3 Seagen Next Generation Antibody Therapeutics Products, Services and Solutions
5.6.4 Seagen Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Seagen Recent Developments
5.7 Astellas
5.7.1 Astellas Profile
5.7.2 Astellas Main Business
5.7.3 Astellas Next Generation Antibody Therapeutics Products, Services and Solutions
5.7.4 Astellas Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Astellas Recent Developments
5.8 Immunomedics
5.8.1 Immunomedics Profile
5.8.2 Immunomedics Main Business
5.8.3 Immunomedics Next Generation Antibody Therapeutics Products, Services and Solutions
5.8.4 Immunomedics Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Immunomedics Recent Developments
5.9 GSK
5.9.1 GSK Profile
5.9.2 GSK Main Business
5.9.3 GSK Next Generation Antibody Therapeutics Products, Services and Solutions
5.9.4 GSK Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 GSK Recent Developments
5.10 Immunocore
5.10.1 Immunocore Profile
5.10.2 Immunocore Main Business
5.10.3 Immunocore Next Generation Antibody Therapeutics Products, Services and Solutions
5.10.4 Immunocore Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Immunocore Recent Developments
5.11 ADC Therapeutics
5.11.1 ADC Therapeutics Profile
5.11.2 ADC Therapeutics Main Business
5.11.3 ADC Therapeutics Next Generation Antibody Therapeutics Products, Services and Solutions
5.11.4 ADC Therapeutics Next Generation Antibody Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 ADC Therapeutics Recent Developments
6 North America
6.1 North America Next Generation Antibody Therapeutics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Next Generation Antibody Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Next Generation Antibody Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Next Generation Antibody Therapeutics Market Dynamics
11.1 Next Generation Antibody Therapeutics Industry Trends
11.2 Next Generation Antibody Therapeutics Market Drivers
11.3 Next Generation Antibody Therapeutics Market Challenges
11.4 Next Generation Antibody Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
【Table of Figures】
List of Tables
Table 1. Global Market Next Generation Antibody Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Next Generation Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Next Generation Antibody Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Next Generation Antibody Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Next Generation Antibody Therapeutics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Next Generation Antibody Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Next Generation Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2024-2029)
Table 11. North America Next Generation Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Next Generation Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Next Generation Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Next Generation Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Next Generation Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Next Generation Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Next Generation Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Next Generation Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Next Generation Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Next Generation Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Next Generation Antibody Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Next Generation Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2024-2029)
Table 26. North America Next Generation Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Next Generation Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Next Generation Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Next Generation Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Next Generation Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Next Generation Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Next Generation Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Next Generation Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Next Generation Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Next Generation Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Next Generation Antibody Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Next Generation Antibody Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Next Generation Antibody Therapeutics Market
Table 40. Global Next Generation Antibody Therapeutics Key Players Headquarters and Area Served
Table 41. Next Generation Antibody Therapeutics Product Solution and Service
Table 42. Global Next Generation Antibody Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Roche Basic Information List
Table 45. Roche Description and Business Overview
Table 46. Roche Next Generation Antibody Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of Roche (2018-2023)
Table 48. Roche Recent Developments
Table 49. Amgen Basic Information List
Table 50. Amgen Description and Business Overview
Table 51. Amgen Next Generation Antibody Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of Amgen (2018-2023)
Table 53. Amgen Recent Developments
Table 54. Pfizer Basic Information List
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer Next Generation Antibody Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of Pfizer (2018-2023)
Table 58. Pfizer Recent Developments
Table 59. Takeda Basic Information List
Table 60. Takeda Description and Business Overview
Table 61. Takeda Next Generation Antibody Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of Takeda (2018-2023)
Table 63. Takeda Recent Developments
Table 64. Daiichi Sankyo Basic Information List
Table 65. Daiichi Sankyo Description and Business Overview
Table 66. Daiichi Sankyo Next Generation Antibody Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of Daiichi Sankyo (2018-2023)
Table 68. Daiichi Sankyo Recent Developments
Table 69. Seagen Basic Information List
Table 70. Seagen Description and Business Overview
Table 71. Seagen Next Generation Antibody Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of Seagen (2018-2023)
Table 73. Seagen Recent Developments
Table 74. Astellas Basic Information List
Table 75. Astellas Description and Business Overview
Table 76. Astellas Next Generation Antibody Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of Astellas (2018-2023)
Table 78. Astellas Recent Developments
Table 79. Immunomedics Basic Information List
Table 80. Immunomedics Description and Business Overview
Table 81. Immunomedics Next Generation Antibody Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of Immunomedics (2018-2023)
Table 83. Immunomedics Recent Developments
Table 84. GSK Basic Information List
Table 85. GSK Description and Business Overview
Table 86. GSK Next Generation Antibody Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of GSK (2018-2023)
Table 88. GSK Recent Developments
Table 89. Immunocore Basic Information List
Table 90. Immunocore Description and Business Overview
Table 91. Immunocore Next Generation Antibody Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of Immunocore (2018-2023)
Table 93. Immunocore Recent Developments
Table 94. ADC Therapeutics Basic Information List
Table 95. ADC Therapeutics Description and Business Overview
Table 96. ADC Therapeutics Next Generation Antibody Therapeutics Products, Services and Solutions
Table 97. Revenue (US$ Million) in Next Generation Antibody Therapeutics Business of ADC Therapeutics (2018-2023)
Table 98. ADC Therapeutics Recent Developments
Table 99. North America Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 100. North America Next Generation Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 101. Europe Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 102. Europe Next Generation Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 103. Asia-Pacific Next Generation Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 105. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 106. Asia-Pacific Next Generation Antibody Therapeutics Market Share by Region (2018-2023)
Table 107. Asia-Pacific Next Generation Antibody Therapeutics Market Share by Region (2024-2029)
Table 108. Latin America Next Generation Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 109. Latin America Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 110. Latin America Next Generation Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 111. Middle East & Africa Next Generation Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 112. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 113. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 114. Next Generation Antibody Therapeutics Market Trends
Table 115. Next Generation Antibody Therapeutics Market Drivers
Table 116. Next Generation Antibody Therapeutics Market Challenges
Table 117. Next Generation Antibody Therapeutics Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Antibody Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Next Generation Antibody Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Next Generation Antibody Therapeutics Market Share by Regions: 2022 VS 2029
Figure 4. Global Next Generation Antibody Therapeutics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Next Generation Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Next Generation Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Next Generation Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Next Generation Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Next Generation Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Antibody Drug Conjugate (ADC)
Figure 11. Global Antibody Drug Conjugate (ADC) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Bispecific Antibody (BsAb)
Figure 13. Global Bispecific Antibody (BsAb) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Next Generation Antibody Therapeutics Market Size Share by Type: 2022 & 2029
Figure 15. North America Next Generation Antibody Therapeutics Revenue Market Share by Type (2018-2029)
Figure 16. Europe Next Generation Antibody Therapeutics Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Next Generation Antibody Therapeutics Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Next Generation Antibody Therapeutics Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Next Generation Antibody Therapeutics Revenue Market Share by Type (2018-2029)
Figure 20. Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Haemophilia Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Other Non-Cancer Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Global Next Generation Antibody Therapeutics Market Size Share by Application: 2022 & 2029
Figure 24. North America Next Generation Antibody Therapeutics Revenue Market Share by Application (2018-2029)
Figure 25. Europe Next Generation Antibody Therapeutics Revenue Market Share by Application (2018-2029)
Figure 26. Asia-Pacific Next Generation Antibody Therapeutics Revenue Market Share by Application (2018-2029)
Figure 27. Latin America Next Generation Antibody Therapeutics Revenue Market Share by Application (2018-2029)
Figure 28. Middle East and Africa Next Generation Antibody Therapeutics Revenue Market Share by Application (2018-2029)
Figure 29. Next Generation Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Next Generation Antibody Therapeutics Market Share in 2022
Figure 31. North America Next Generation Antibody Therapeutics Market Share by Country (2018-2029)
Figure 32. United States Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 33. Canada Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 34. Germany Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 35. France Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 36. U.K. Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 37. Italy Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 38. Russia Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific Next Generation Antibody Therapeutics Market Share by Region (2018-2029)
Figure 41. China Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 42. Japan Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 43. South Korea Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 45. India Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 46. Australia Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 47. Latin America Next Generation Antibody Therapeutics Market Share by Country (2018-2029)
Figure 48. Mexico Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 49. Brazil Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Next Generation Antibody Therapeutics Market Share by Country (2018-2029)
Figure 51. Turkey Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 53. UAE Next Generation Antibody Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report